Shenzhen Kangtai Biological Products Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 58.8%

Shenzhen Kangtai Biological Products Co Ltd strategic asset allocation index. Shenzhen Kangtai Biological Products Co Ltd (300601) has a Strategic Asset Allocation Index of 58.8% as of June 2023. Strategic assets (PP&E of CN¥5.52 Billion plus long-term investments of CN¥-) total CN¥5.52 Billion, measured against net assets of CN¥9.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300601 equity to assets ratio to measure how much of total assets are equity-financed.

SAAI

58.8%
Strategic Assets / Net Assets

Strategic Assets

CN¥5.52 Billion
PP&E + LT Investments

PP&E

CN¥5.52 Billion
CNY

Net Assets

CN¥9.39 Billion
CNY

Strategic Asset Allocation Index of Shenzhen Kangtai Biological Products Co Ltd (2016–2021)

Strategic asset allocation index of Shenzhen Kangtai Biological Products Co Ltd from 2016 to 2021. This chart shows how Shenzhen Kangtai Biological Products Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the index stands at 58.8%, representing strategic assets of CN¥5.52 Billion against net assets of CN¥9.39 Billion CNY. Check tangible equity quality of Shenzhen Kangtai Biological Products Co to evaluate the tangible quality of the company's equity base.

Shenzhen Kangtai Biological Products Co Ltd Strategic Asset Allocation Index by Year (2016–2021)

Shenzhen Kangtai Biological Products Co Ltd strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Kangtai Biological Products Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shenzhen Kangtai Biological Products Co (300601) total market value.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2021 44.9% CN¥4.12 Billion CN¥4.12 Billion CN¥- CN¥9.17 Billion ▲ +14.4 pp
2020 30.5% CN¥2.28 Billion CN¥2.28 Billion CN¥- CN¥7.46 Billion ▼ -19.1 pp
2019 49.6% CN¥1.37 Billion CN¥1.37 Billion CN¥- CN¥2.75 Billion ▼ -13.8 pp
2018 63.5% CN¥1.17 Billion CN¥1.17 Billion CN¥- CN¥1.84 Billion ▼ -16.2 pp
2017 79.7% CN¥853.25 Million CN¥853.25 Million CN¥- CN¥1.07 Billion ▼ -22.7 pp
2016 102.3% CN¥752.09 Million CN¥752.09 Million CN¥- CN¥735.00 Million —
pp = percentage points